Accrual of organ damage over time in patients with systemic lupus erythematosus.
about
Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayA phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusFactors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception CohortA proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis TrialPredictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and PortugalPeripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX)Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus.New classification criteria for systemic lupus erythematosus correlate with disease activityBrief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus.Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus CohortEvaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus.Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus.Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts WorldwideComparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritisPrednisone, lupus activity, and permanent organ damage.Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care.A quality indicator set for systemic lupus erythematosus.Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness.Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment.The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care.Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome.Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.Quantifying the burden of steroid-related damage in SLE in the Hopkins Lupus Cohort.Association of objectively measured physical activity and sedentary time with arterial stiffness in women with systemic lupus erythematosus with mild disease activity.
P2860
Q26746697-87A7CDE5-86AB-427A-98D1-8E51365455E6Q28254310-8D937124-AD99-4EAB-B824-CAE0AA183739Q28608340-68DECF4F-18B6-43A1-BC86-49E5AC2CC7D0Q31029893-B0CC2EFC-EA95-417B-8C53-DFC129F3CD5FQ33448450-9343489D-8BF8-46A3-8FD5-072F3C02E792Q33504486-4CFBEA6A-08D8-47B2-B5F6-D1CB6D382519Q33511924-AC9DB2BC-5425-4B2B-AF90-8AE840293BF7Q33555419-A9C9C091-1D2A-47AF-B967-944FD038D902Q34114253-C9E3FA28-AE09-4DCD-B030-F02BBF2F6593Q34492782-3BC4A324-24A6-4C7A-B6CF-A5BB6D87F70CQ35146106-B535FD7B-1B72-4575-8597-3073738B3033Q35229284-3E9F04FC-62CE-4FAB-A7C3-72B2B77B28DDQ35657280-1168891A-862B-4CA8-B910-C8C34473A838Q35743200-D8EB08EB-4D1E-48E6-9681-1B55F79F7144Q35993027-018D1EE4-BAF0-48BC-95DA-BB4B30FA0B02Q36192962-699B137E-27B4-4C8A-9C64-A4800E7AF9CCQ36338094-75D5A70A-2A37-4666-AA05-937F3495743FQ36681801-78C41D26-73D2-4EB9-8428-B0C36793A7D7Q36761678-EA57E482-A18A-43D2-8CF1-A9D9E44F3C41Q37121787-C6AA991E-4DFF-4991-B1FD-CABAC8E66E1CQ37356757-517B0B86-572E-4CDF-A326-9667F6A18A7FQ37456307-60CFB847-12F8-4059-B742-63E604385051Q37586440-D10E3AE9-5320-4D5D-8297-357BAC5E3530Q37627356-7273C1FA-5F0E-481C-B37C-B13DFECDFCEEQ37673352-D1F1CBCC-17F2-4314-9A79-930A25CA5424Q38608906-37883841-DB3C-469E-B4C3-960225487B5EQ38635119-7BFD9EE8-F4FF-4F6A-90E6-F498F3090C27Q42360078-D4095A97-F461-49F5-9CB2-6547429586BCQ42844966-38BE0A66-5E88-403E-9FA1-512BB6463F89Q44750823-D0401BBD-84E8-40B4-BE1D-F987910A6D5EQ49359821-837B9866-EC65-4174-9875-86D3182D7F37Q54965930-71A145E7-3C0F-47B9-9E95-3715BA5F2E37Q55280394-F1B82392-3FDA-46ED-8E23-C713322D0CEC
P2860
Accrual of organ damage over time in patients with systemic lupus erythematosus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Accrual of organ damage over time in patients with systemic lupus erythematosus.
@en
Accrual of organ damage over time in patients with systemic lupus erythematosus.
@nl
type
label
Accrual of organ damage over time in patients with systemic lupus erythematosus.
@en
Accrual of organ damage over time in patients with systemic lupus erythematosus.
@nl
prefLabel
Accrual of organ damage over time in patients with systemic lupus erythematosus.
@en
Accrual of organ damage over time in patients with systemic lupus erythematosus.
@nl
P2093
P1476
Accrual of organ damage over time in patients with systemic lupus erythematosus.
@en
P2093
Dominique Ibañez
Lai-Shan Tam
Murray B Urowitz
Proton Rahman
P304
P407
P577
2003-09-01T00:00:00Z